Benzinga | Jul 12, 2021 04:44AM EDT

Keybanc Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $555

Keybanc analyst Paul Knight maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $520 to $555.